## Mycobacterium leprae: Transmission, Epidemiology, and Host Factors ### Correct Answer Analysis **Approximately 95% of exposed individuals develop clinical disease is FALSE.** This statement grossly overestimates the infectivity of M. leprae. The actual epidemiology is: - **~95% of exposed individuals have natural immunity** and do NOT develop disease - Only **~5% of exposed contacts** progress to clinical leprosy - Among those infected, disease manifestation depends on: - Cell-mediated immunity (CMI) status - Genetic polymorphisms (HLA associations, NOD2/CARD15 variants) - Nutritional status - Duration and intensity of exposure This is a critical distinction: *high exposure ≠ high disease risk*. ### Why the Other Options Are Correct | Statement | Evidence | |-----------|----------| | **Prolonged close contact with untreated lepromatous case** | Lepromatous patients have high bacillary loads in skin and nasal secretions; household contacts have highest risk; tuberculoid cases are poorly infectious | | **Respiratory tract as main portal** | M. leprae is shed in nasal secretions; inhalation is the primary route; skin inoculation is rare and requires breaks in skin barrier | | **Genetic susceptibility & CMI determine progression** | HLA-DR3 and HLA-DQ1 associated with tuberculoid (protective); HLA-DQ1 with lepromatous (permissive); IL-10 polymorphisms affect disease severity | ### Key Point: **M. leprae has LOW infectivity despite high transmissibility in endemic areas.** The distinction is crucial: - **Transmissibility** = ability to spread (high in lepromatous disease) - **Infectivity** = ability to cause disease in exposed person (low, ~5%) ### High-Yield: **Natural immunity in ~95% of contacts** is why: - Mass chemotherapy of cases (not contacts) is the WHO strategy - Household contacts need surveillance, not prophylaxis - BCG vaccination offers 50–80% protection (boosts CMI) - Leprosy elimination is achievable despite ongoing transmission ### Mnemonic: **"5-95 Rule"** — 5% of exposed develop disease; 95% are naturally immune. ### Clinical Pearl: A patient with tuberculoid leprosy (strong CMI) is far less infectious than one with lepromatous leprosy (weak CMI), even though the tuberculoid patient has fewer bacilli. This paradox reflects the role of CMI in both disease control AND transmission prevention.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.